newsfilter
← Latest News
GlobeNewswire·

Vivos Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational Update

Year-over-year product revenue increased 8%, and year-over-year operating expenses decreased 5% as Vivos sets the stage for its Sleep Center of Nevada acquisition and continued advancement of its new marketing and